News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Waters Corporation Cuts Q4 View on Lower Orders for New Instruments
December 12, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Dec 11 (Reuters) - Drug research tools maker Waters Corp cut its fourth-quarter outlook, citing weaker than expected orders for new instruments due to the deteriorating global economy, sending shares down 12 percent.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
MORE ON THIS TOPIC
Mergers & acquisitions
SpringWorks Surges on Potential $3.5B Merck KGaA Buyout
April 25, 2025
·
2 min read
·
Tristan Manalac
Earnings
Gilead’s PrEP Launch Full Speed Ahead Despite Macro Pressures on HIV Space
April 25, 2025
·
3 min read
·
Tristan Manalac
Earnings
BMS Reports Mixed Earnings as Growth Portfolio Makes Up for Generic Pressure
April 24, 2025
·
2 min read
·
Dan Samorodnitsky
Earnings
Tariff Uncertainty Reigns Over Q1 Earnings, With Merck Taking $200M Blow So Far
April 24, 2025
·
3 min read
·
Annalee Armstrong